SCHEMBL26337151

SCHEMBL26337151

c1ccc(-c2c(-c3ccccc3)c3cc(-c4cccc(N(c5ccc6c(c5)oc5ccccc56)c5cccc6c5ccc5ccccc56)c4)ccc3c3ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ HCRTR1 O43613 1/20 0.33
▸ PLA2G2A P14555 2/20 0.32
▸ PLA2G4A P47712 2/20 0.32
▸ DUSP3 P51452 1/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ KDM4E B2RXH2 3/20 0.31
▸ MAPT P10636 3/20 0.31
▸ HPGD P15428 3/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ THRB P10828 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ CASP3 P42574 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26339666 0.96 PLA2G2A (0.33) HCRTR1PLA2G2APLA2G4ADUSP3PLA2G10
SCHEMBL26337153 0.96 HCRTR1 (0.34) CYP1A1CYP1A2CYP1B1HCRTR1PLA2G2A
SCHEMBL26336976 0.95 KDM4E (0.34) CYP1A1CYP1A2CYP1B1PLA2G2APLA2G4A
SCHEMBL26335475 0.94 DUSP3 (0.34) CYP1A1CYP1A2CYP1B1DUSP3AHR
SCHEMBL26337165 0.93 HCRTR1 (0.33) CYP1A2HCRTR1PLA2G2APLA2G4ADUSP3
SCHEMBL26337647 0.92 CYP1A1 (0.39) CYP1A1CYP1A2CYP1B1KDM4EMAPT
SCHEMBL26339670 0.92 PLA2G2A (0.34) HCRTR1PLA2G2APLA2G4ADUSP3PLA2G10
SCHEMBL26045752 0.91 CYP1A1 (0.37) CYP1A1CYP1A2CYP1B1HCRTR1PLA2G2A
SCHEMBL26339509 0.91 PLA2G2A (0.35) CYP1A1CYP1A2PLA2G2APLA2G4APLA2G10
SCHEMBL26336978 0.91 PLA2G2A (0.35) CYP1A1CYP1A2CYP1B1HCRTR1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 CYP1A1 1240/4885CYP1A2 2105/4885CYP1B1 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback